Yuko Takeba, Toshio Kumai, Naoki Matsumoto, Sachiko Nakaya, Yoshimitsu Tsuzuki, Yohei Yanagida, & Shinichi Kobayashi. (2007). Irinotecan Activates p53 With Its Active Metabolite, Resulting in Human Hepatocellular Carcinoma Apoptosis. Elsevier.
Chicago Style (17th ed.) CitationYuko Takeba, Toshio Kumai, Naoki Matsumoto, Sachiko Nakaya, Yoshimitsu Tsuzuki, Yohei Yanagida, and Shinichi Kobayashi. Irinotecan Activates P53 With Its Active Metabolite, Resulting in Human Hepatocellular Carcinoma Apoptosis. Elsevier, 2007.
MLA (9th ed.) CitationYuko Takeba, et al. Irinotecan Activates P53 With Its Active Metabolite, Resulting in Human Hepatocellular Carcinoma Apoptosis. Elsevier, 2007.
Warning: These citations may not always be 100% accurate.